Want to join the conversation?
$AMGN 2Q15 PR: Total revenues increased 4% versus 2Q14 to $5,370MM, with 6% product sales growth driven primarily by Enbrel, Prolia, Sensipar, Kyprolis and XGEVA. GAAP net income was $1,653MM compared to $1,547MM in 2Q14. GAAP EPS was $2.15 compared to $2.01 in 2Q14.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!